Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 26, 597 (1 June 2008) | doi:10.1038/nbt0608-597a
Patent reform stalls
Abstract
A US District Court has put to rest a battle between the biotech and pharma industries and the US Patent and Trademark Office (USPTO) over patent reform. The USPTO's proposed changes would have radically altered the way the US patent system works and were fiercely opposed by the biotech and pharma industries.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
